This webinar consists of 2 sessions
December 12 & 13, 2023
Day 1: 12:00 - 2:00 pm - Day 2: 1:00 - 3:00 pm
Topics to be discussed:
- The importance of assessing the drug interactions involving therapeutic protein products, interactions cause by change of gastric pH level, and interactions affecting combined oral contraceptives.
- How to evaluate those drug interaction potentials for investigational drugs
- General considerations for designing clinical drug interaction studies and how the results may inform drug labeling
- Utility of the lists of drugs available on the FDA drug interaction websites and the relevance to drug development and clinical practice
If you can't attend, these webinars are normally recorded and available for later viewing, but you should register for easier access.
Link to the Webinar details and registration
------------------------------
Mark Arnold Ph.D., FAAPS
Westampton, NJ
[email protected]Bioanalytical Solution Integration
LinkedIn:
https://www.linkedin.com/in/markearnoldphd/Website & Blog: Bioanalysis & Biomarkers <bioanalysisandbiomarkers.blogspot.com>
------------------------------
</bioanalysisandbiomarkers.blogspot.com>